LORUKAFUSP ALFA
UNII PL21OR4LXE

Substance Identification & Data

This profile provides standardized clinical and technical data for Lorukafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PL21OR4LXE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2131168-99-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PL21OR4LXE

CAS Registry Number

2131168-99-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LORUKAFUSP ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C162537

National Cancer Institute reference terminology for clinical and research data.

INN ID

10954

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lorukafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.